Education and Training

PhD Doctor Of Philosophy, University of Queensland 2008

Bakrania, B., Du Toit, E., Wagner, K.-H., Headrick, J., & Bulmer, A. (2016). Pre- or post-ischemic bilirubin ditaurate treatment reduces oxidative tissue damage and improves cardiac function. International Journal of Cardiology, 202, 27–33. Donner, D., Elliott, G., Beck, B., Bulmer, A., Lam, A., Headrick, J., & Du Toit, E. (2016). Trenbolone improves cardiometabolic risk factors and myocardial tolerance to ischemia-reperfusion in male rats with testosterone-deficient metabolic syndrome. Endocrinology, 1–15. Boon, C., Hawkins, C., Coombes, J., Wagner, K., & Bulmer, A. (2015). Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein/lipid oxidation in physiologically relevant hyperbilirubinemic serum. Free Radical Biology and Medicine, 86, 259–268. Boon, C., Lam, A., Gopalan, V., Benzie, I., F., Briskey, D., Coombes, J., S., … Bulmer, A. (2015). Endogenously elevated bilirubin modulates kidney function and protects from circulating oxidative stress in a rat model of adenine-induced kidney failure. Scientific Reports, 5, 15482–1–15482–16. Donner, D., Beck, B., Bulmer, A., Lam, A., & Du Toit, E. (2015). Improvements in body composition, cardiometabolic risk factors and insulin sensitivity with trenbolone in normogonadic rats. Steroids, 94, 60–69.